Induction of seizures by the potent K+ channel-blocking scorpion venom peptide toxins tityustoxin-Kα and pandinustoxin-Kα

Epilepsy Research

Volumn 34, Issue 2-3, 1999, Pages 177-186

  Juhng, K N ^a   Kokate, T G ^a   Yamaguchi, S ^a   Kim, B Y ^a   Rogowski, R S ^b   Blaustein, M P ^b   Rogawski, M A ^a  

^a Sect Clin and Exp Neuropsychol   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

4 aminopyridine; AMPA receptor antagonist; K+ channel blocker; Pandinustoxin K ; Paxilline; Tityustoxin K

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 4 AMINOPYRIDINE; AMPA RECEPTOR ANTAGONIST; DIZOCILPINE; PANDINUSTOXIN; PAXILLINE; PHENYTOIN; POTASSIUM CHANNEL BLOCKING AGENT; SCORPION VENOM; TITYUS TOXIN; TOXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; ELECTROENCEPHALOGRAM; GRAND MAL EPILEPSY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; SEIZURE; TOXIN ANALYSIS;

4-AMINOPYRIDINE; ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; BENZODIAZEPINES; CARBAMAZEPINE; DIZOCILPINE MALEATE; ELECTROENCEPHALOGRAPHY; EXCITATORY AMINO ACID ANTAGONISTS; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; NEUROPROTECTIVE AGENTS; PHENYTOIN; POTASSIUM CHANNEL BLOCKERS; SCORPION VENOMS; SEIZURES;

EID: 0032891686     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(98)00111-9     Document Type: Article

References (34)

1. Amitai Y., Mines Y., Aker M., Goitein K. Scorpion sting in children. A review of 51 cases. Clin. Pediatr. (Phila.). 24:1985;136-140.
2. 2+-dependent releasable pool of glutamate in striatal synaptosomes associated with dendrotoxin-induced potassium channel blockade. J. Neural Transm. Gen. Sect. 80:1990;167-179.
3. Coleman M.H., Yamaguchi S., Rogawski M.A. Protection against dendrotoxin-induced clonic seizures in mice by anticonvulsant drugs. Brain Res. 575:1992;138-142.
4. Cherubini E., Neuman R., Rovira C., Ben Air Y. Epileptogenic properties of the mast cell degranulating peptide in CA3 hippocampal neurones. Brain Res. 445:1988;91-100.
5. Donevan S.D., Rogawski M.A. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron. 10:1993;51-59.
6. Dorandeu F., Wetherell J., Pernot-Marino I., Tattersall J.E.H., Fosbraey P., Lallement G. Effects of excitatory amino acid antagonists on dendrotoxin-induced increases in neurotransmitter release and epileptiform bursting in rat hippocampus in vitro. J. Neurosci. Res. 48:1997;499-506.
7. Eccles C.U., Rogowski R.S., Gu X., Alger B.E., Blaustein M.P. Tityustoxin-Kα, from scorpion venom, blocks voltage-gated, non-inactivating potassium current in cultured central neurons. Neuropharmacology. 33:1994;1523-1528.
8. Fragoso-Veloz J., Massieu L., Alvarado R., Tapia R. Seizures and wet-dog shakes induced by 4-aminopyridine, and their potentiation by nifedipine. Eur. J. Pharmacol. 178:1990;275-284.
9. Fueta Y., Avoli M. Tetraethylammonium-induced epileptiform activity in young and adult rat hippocampus. Brain Res. Dev. Brain Res. 72:1993;51-58.
10. + channel inhibitors. Eur. J. Pharmacol. 160:1989;173-177.
11. Gustafsson B., Galvan M., Grafe P., Wigstrom H. A transient outward current in a mammalian central neurone blocked by 4-aminopyridine. Nature. 299:1982;252-254.
12. Isacoff E.Y., Jan Y.N., Jan L.Y. Evidence for the formation of heteromultimeric potassium channels in Xenopus oocytes. Nature. 345:1990;530-534.
13. Knaus H.G., McManus O.B., Lee S.H., Schmalhofer W.A., Garcia-Calvo M., Helms L.M., Sanchez M., Giangiacomo K., Reuben J.P., Smith A.B. III, Kaczorowski G.J., Garcia M.L. Tremorgenic indole alkaloids potently inhibit smooth muscle high-conductance calcium-activated potassium channels. Biochemistry. 33:1994;5819-5828.
14. Mathie A., Wooltorton J.R., Watkins C.S. Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents. Gen. Pharmacol. 30:1998;13-24.
15. Kf) in rat dorsal root ganglion neurones. J. Physiol. (Lond.). 503(Pt 2):1997;285-301.
16. Morales-Villagrán A., Tapia R. Preferential stimulation of glutamate release by 4-aminopyridine in rat striatum in vivo. Neurochem. Int. 28:1996;35-40.
17. Morales-Villagrán A., Ureña-Guerrero M.E., Tapia R. Protection by NMDA receptor antagonists against seizures induced by intracerebral administration of 4-aminopyridine. Eur. J. Pharmacol. 305:1996;87-93.
18. Perreault P., Avoli M. Physiology and pharmacology of epileptiform activity induced by 4-aminopyridine in rat hippocampal slices. J. Neurophysiol. 65:1991;771-785.
19. Rogawski, M.A., Donevan, S.D., 1998. AMPA receptors in epilepsy and as targets for antiepileptic drugs. In: Delgado-Escueta, A.V., Wilson, W., Olsen, R.W., Porter, R.J. (Eds.), Jasper's Basic Mechanisms of the Epilepsies. Raven, New York, in press.
20. Rogawski M.A., Porter R.J. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev. 42:1990;223-280.
21. + channels blocked by α-dendrotoxin in synaptosomes. Proc. Natl. Acad. Sci. USA. 91:1994;1475-1479.
22. + channels. Mol. Pharmacol. 50:1996;1167-1177.
23. Ruppersberg J.P., Schroter K.H., Sakmann B., Stocker M., Sewing S., Pongs O. Heteromeric channels formed by rat brain potassium-channel proteins. Nature. 345:1990;535-537.
24. Rutecki P.A., Lebeda F.J., Johnston D. Epileptiform activity in the hippocampus produced by tetraethylammonium. J. Neurophysiol. 64:1990;1077-1088.
25. Sanchez M., McManus O.B. Paxilline inhibition of the α-subunit of the high-conductance calcium-activated potassium channel. Neuropharmacology. 35:1996;963-968.
26. Segal M., Rogawski M.A., Barker J.L. A transient potassium conductance regulates the excitability of cultured hippocampal and spinal neurons. J. Neurosci. 4:1984;604-609.
27. v1.1 potassium channel causes epilepsy in mice. Neuron. 20:1998;809-819.
28. Souza C., Fernandes V.S., Farah M.B. Effects of diazepam and phenytoin on the severe experimental intoxication induced by Tityus serrulatus scorpion venom. J. Venom. Anim. Toxins. 3:1997;73.
29. Thompson S.M., Fortunato C., McKinney R.A., Muller M., Gahwiler B.H. Mechanisms underlying the neuropathological consequences of epileptic activity in the rat hippocampus in vitro. J. Comp. Neurol. 372:1996;515-528.
30. 2+ and glutamate release. J. Neurochem. 52:1989;1693-1699.
31. 2+-dependent release of glutamate from guinea-pig cerebrocortical synaptosomes. J. Neurochem. 52:1989;201-206.
32. + channel. Mol. Pharmacol. 44:1993;430-436.
33. Yamaguchi S., Donevan S.D., Rogawski M.A. Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBQX in maximal electroshock and chemoconvulsant models. Epilepsy Res. 15:1993;179-184.
34. Yamaguchi S., Rogawski M.A. Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice. Epilepsy Res. 11:1992;9-16.